CXA-10: Clinical Trials

6 trials of CXA-10, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed, 1 recruiting, 1 withdrawn. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 3, Completed 1, Recruiting 1, Withdrawn 1

Follow CXA-10: new trials by email Literature Review of CXA-10 trials Research Report on CXA-10

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
CXA-10, Matching Placebo - Asthma, Obesity
Phase 2RecruitingUniversity of Colorado, Denver602023-02-082025-06-10
Oral CXA-10 in Pulmonary Arterial Hypertension
CXA-10 - Pulmonary Arterial Hypertension
Phase 2TerminatedGladwin, Mark, MD12019-10-312022-01-12
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
CXA-10 - PAH
Phase 2TerminatedComplexa, Inc.332019-08-092020-08-26
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
75mg CXA-10, 150mg CXA-10, Placebo - PAH
Phase 2TerminatedComplexa, Inc.692018-08-012020-08-10
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
CXA-10 - Primary Focal Segmental Glomerulosclerosis
Phase 2CompletedComplexa, Inc.332018-04-152020-08-03
Anti-Inflammatory Lipid Mediators in Asthma
CXA-10, Placebo - Asthma
Phase 2WithdrawnSally E. Wenzel MD2018-09-21

Conditions studied

Pulmonary Arterial Hypertension (3)  ·  Asthma (2)  ·  Cardiovascular Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Familial Primary Pulmonary Hypertension (2)  ·  Hypertension (2)  ·  Hypertension, Pulmonary (2)  ·  Lung Diseases (2)  ·  Obesity (2)  ·  Vascular Diseases (2)  ·  Kidney Diseases (1)  ·  Nephrotic Syndrome (1)  ·  Proteinuria (1)

Sponsors

Complexa, Inc. (3)  ·  Gladwin, Mark, MD (1)  ·  Sally E. Wenzel MD (1)  ·  University of Colorado, Denver (1)

Countries

United States (6)  ·  United Kingdom (2)

Top investigators

Theo Danoff, MD (2)  ·  Fernando Holguin, MD, MPH (1)  ·  Marc Simon, MD (1)  ·  Sally E Wenzel, MD (1)  ·  Theodore Danoff, MD (1)

NIH funding

P01HL103455 (1), R01HL132550 (1), R61HL157069 (1)